Research in the UAE

Incidence and prevalence of neurological disorders in the UAE

Published on Fri, 3 Nov 2023

Incidence and prevalence of neurological disorders in the United Arab Emirates: a systematic review

A systematic review assessed the incidence and prevalence of neurological disorders in the UAE, revealing significant gaps in data. Eight studies were analyzed, with half focused on multiple sclerosis, showing an average crude prevalence of 56/100,000. Other studies addressed headaches, meningitis, cerebral venous thrombosis, and brain tumors.

The review underscores the urgent need for population-based, longitudinal studies to generate reliable epidemiological data and support healthcare capacity planning for the UAE’s evolving neurological needs.

Related research

Learn More
Switching from Fingolimod/Natalizumab to Cladribine Without Rebound
Fri, 1 Dec 2023

Switching from Fingolimod/Natalizumab to Cladribine Without Rebound

Learn More
Learn More
Adherence Challenges for High-Efficacy MS Therapies
Fri, 22 May 2020

Adherence Challenges for High-Efficacy MS Therapies

Learn More
Learn More
Living with MS: A Biopsychosocial Perspective
Tue, 17 Aug 2021

Living with MS: A Biopsychosocial Perspective